Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Progression of Damage in Ulcerative Colitis

NCT03955328 is registered in ClinicalTrials.gov with David Garcia Cinca as lead sponsor.

NCT NCT03955328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03955328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Progression of Damage in Ulcerative Colitis
Lead sponsor
David Garcia Cinca
Phase
Not applicable
Overall status
Unknown status
Start date
June 15, 2019
Completion date
June 15, 2020
Enrollment
20 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis